Back to Journals » Therapeutics and Clinical Risk Management » Volume 17
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,005 | Dovepress* | 7,701+ | 561 | 8,262 | |
PubMed Central* | 3,304 | 751 | 4,055 | ||
Totals | 11,005 | 1,312 | 12,317 | ||
*Since 30 July 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar